Carbohydrate chain of ganglioside GM1 as a ligand: identification of the binding strategies of three 15 mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin.

The branched pentasaccharide chain of ganglioside GM1 is a prominent cell surface ligand, for example, for cholera toxin or tumor growth-regulatory homodimeric galectins. This activity profile via protein recognition prompted us to examine the binding properties of peptides with this specificity. Our study provides insights into the mechanism of molecular interaction of this thus far unexplored size limit of the protein part. We used three pentadecapeptides in a combined approach of mass spectrometry, NMR spectroscopy and molecular modelling to analyze the ligand binding in solution. Availability of charged and hydrophobic functionalities affected the intramolecular flexibility of the peptides differently. Backfolding led to restrictions in two cases; the flexibility was not reduced significantly by association of the ligand in its energetically privileged conformations. Major contributions to the interaction energy arise from the sialic acid moiety contacting Arg/Lys residues and the N-terminal charge. Considerable involvement of stacking between the monovalent ligand and aromatic rings could not be detected. This carbohydrate binding strategy is similar to how an adenoviral fiber knob targets sialylated glycans. Rational manipulation for an affinity enhancement can now be directed to reduce the flexibility, exploit the potential for stacking and acquire the cross-linking capacity of the natural lectins by peptide attachment to a suitable scaffold.

[1]  Jesús Jiménez-Barbero,et al.  Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. , 2003, Biochemistry.

[2]  J. Martial,et al.  Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide , 1994, Protein science : a publication of the Protein Society.

[3]  A. Heck,et al.  Binding of selected carbohydrates to apo-concanavalin A studied by electrospray ionization mass spectrometry , 2000 .

[4]  S. Cusack,et al.  Crystal Structure of Species D Adenovirus Fiber Knobs and Their Sialic Acid Binding Sites , 2004, Journal of Virology.

[5]  B. Stierstorfer,et al.  Animal Lectins as Cell Adhesion Molecules , 1998, Cells Tissues Organs.

[6]  J. Aqvist,et al.  A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.

[7]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[8]  A. May,et al.  Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 A resolution. , 1998, Molecular cell.

[9]  J. Åqvist,et al.  Ligand binding affinities from MD simulations. , 2002, Accounts of chemical research.

[10]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[11]  Hans-Joachim Gabius,et al.  The How and Why of Protein-carbohydrate Interaction: A Primer to the Theoretical Concept and a Guide to Application in Drug Design , 2004, Pharmaceutical Research.

[12]  H. Gabius,et al.  Eukaryotic glycosylation: whim of nature or multipurpose tool? , 1999, Cellular and Molecular Life Sciences CMLS.

[13]  J. Jiménez-Barbero,et al.  Towards Defining the Role of Glycans as Hardware in Information Storage and Transfer: Basic Principles, Experimental Approaches and Recent Progress , 2000, Cells Tissues Organs.

[14]  A. Heck,et al.  Analysis of protein-carbohydrate interaction at the lower size limit of the protein part (15-mer peptide) by NMR spectroscopy, electrospray ionization mass spectrometry, and molecular modeling. , 2002, Biochemistry.

[15]  Mark von Itzstein,et al.  Sialic Acid Recognition by Vibrio cholerae Neuraminidase* , 2004, Journal of Biological Chemistry.

[16]  L. Curtiss,et al.  Gaussian‐1 theory: A general procedure for prediction of molecular energies , 1989 .

[17]  H. Dyson,et al.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.

[18]  J. Holgersson,et al.  Rapid and sensitive GC/MS characterization of glycolipid released Galalpha1,3Gal-terminated oligosaccharides from small organ specimens of a single pig. , 1998, Glycobiology.

[19]  Y. Okahata,et al.  Selection of ganglioside GM1‐binding peptides by using a phage library , 1999, FEBS letters.

[20]  H. Gabius,et al.  Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. , 2004, Bioconjugate chemistry.

[21]  C. F. Brewer,et al.  Binding and cross-linking properties of galectins. , 2002 .

[22]  P. Emsley,et al.  The Crystal Structure of Tetanus Toxin Hc Fragment Complexed with a Synthetic GT1b Analogue Suggests Cross-linking between Ganglioside Receptors and the Toxin* , 2001, The Journal of Biological Chemistry.

[23]  H. Gabius,et al.  Biological Information Transfer Beyond the Genetic Code: The Sugar Code , 2000, Naturwissenschaften.

[24]  H Kaltner,et al.  NMR-based, molecular dynamics- and random walk molecular mechanics-supported study of conformational aspects of a carbohydrate ligand (Gal beta 1-2Gal beta 1-R) for an animal galectin in the free and in the bound state. , 1996, Biochemical and biophysical research communications.

[25]  F. Gao,et al.  A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis. , 2003, Cancer research.

[26]  A. Imberty,et al.  Structure and conformation of complex carbohydrates of glycoproteins, glycolipids, and bacterial polysaccharides. , 1999, Annual review of biophysics and biomolecular structure.

[27]  S. Pérez,et al.  Structure, conformation, and dynamics of bioactive oligosaccharides: theoretical approaches and experimental validations. , 2000, Chemical reviews.

[28]  Hans-Joachim Gabius,et al.  Galectin-1 Is a Major Receptor for Ganglioside GM1, a Product of the Growth-controlling Activity of a Cell Surface Ganglioside Sialidase, on Human Neuroblastoma Cells in Culture* , 1998, The Journal of Biological Chemistry.

[29]  R. Cotter,et al.  Study of peptide-sugar non-covalent complexes by infrared atmospheric pressure matrix-assisted laser desorption/ionization. , 2004, Journal of mass spectrometry : JMS.

[30]  F. Quiocho Protein-carbohydrate interactions: basic molecular features , 1989 .

[31]  R. Roy A Decade of Glycodendrimer Chemistry , 2003 .

[32]  C. Wright,et al.  Crystallographic refinement and structure analysis of the complex of wheat germ agglutinin with a bivalent sialoglycopeptide from glycophorin A. , 1993, Journal of molecular biology.

[33]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[34]  Albert J R Heck,et al.  Determination of structural and functional overlap/divergence of five proto‐type galectins by analysis of the growth‐regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells , 2005, International journal of cancer.

[35]  C. Wright,et al.  2.2 A resolution structure analysis of two refined N-acetylneuraminyl-lactose--wheat germ agglutinin isolectin complexes. , 1990, Journal of molecular biology.

[36]  H Kaltner,et al.  A New Combined Computational and NMR‐Spectroscopical Strategy for the Identification of Additional Conformational Constraints of the Bound Ligand in an Aprotic Solvent , 2000, Chembiochem : a European journal of chemical biology.

[37]  A. Heck,et al.  Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells , 2003, Oncogene.

[38]  H. Gabius,et al.  First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. , 2003, Organic & biomolecular chemistry.

[39]  E. Merritt,et al.  Structural studies of receptor binding by cholera toxin mutants , 1997, Protein science : a publication of the Protein Society.

[40]  W. Somers,et al.  Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1 , 2000, Cell.

[41]  S. Ugurel,et al.  CD4+CD7− leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death , 2002, Leukemia.

[42]  K. Sekar,et al.  Structure/activity studies of anti-inflammatory peptides based on a conserved peptide region of the lectin domain of E-, L- and P-selectin. , 1996, Glycobiology.

[43]  J. Jiménez-Barbero,et al.  Chemical Biology of the Sugar Code , 2004, Chembiochem : a European journal of chemical biology.

[44]  D. Bolam,et al.  Carbohydrate-binding modules: fine-tuning polysaccharide recognition. , 2004, The Biochemical journal.

[45]  J. D. San Antonio,et al.  Novel Design of Peptides to Reverse the Anticoagulant Activities of Heparin and other Glycosaminoglycans , 2001, Thrombosis and Haemostasis.

[46]  J M Thornton,et al.  Analysis and prediction of carbohydrate binding sites. , 2000, Protein engineering.

[47]  Hans-Joachim Gabius,et al.  Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. , 2004, Journal of molecular biology.

[48]  B. Rotblat,et al.  Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. , 2004, Cancer research.

[49]  R. Liskamp,et al.  Wedgelike Glycodendrimers as Inhibitors of Binding of Mammalian Galectins to Glycoproteins, Lactose Maxiclusters, and Cell Surface Glycoconjugates , 2001, Chembiochem : a European journal of chemical biology.

[50]  S. Harrison,et al.  High‐resolution structure of a polyomavirus VP1‐oligosaccharide complex: implications for assembly and receptor binding , 1997, The EMBO journal.

[51]  K. Kayser,et al.  Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. , 2004, European journal of biochemistry.

[52]  A. Heck,et al.  Direct determination of solution binding constants for noncovalent complexes between bacterial cell wall peptide analogues and vancomycin group antibiotics by electrospray ionization mass spectrometry , 1998 .

[53]  G. Varani,et al.  Current topics in RNA-protein recognition: control of specificity and biological function through induced fit and conformational capture. , 2001, Biochemistry.

[54]  H. Gabius,et al.  Glycohistochemistry: The Why and How of Detection and Localization of Endogenous Lectins , 2001, Anatomia, histologia, embryologia.

[55]  J F Vliegenthart,et al.  Role of aromatic amino acids in carbohydrate binding of plant lectins: Laser photo chemically induced dynamic nuclear polarization study of hevein domain‐containing lectins , 1997, Proteins.

[56]  H. Gabius,et al.  Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. , 1999, Glycobiology.

[57]  Barry J. Hardy,et al.  THE GLYCOSIDIC LINKAGE FLEXIBILITY AND TIME-SCALE SIMILARITY HYPOTHESES , 1997 .

[58]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[59]  M. Germann,et al.  Design of Peptides with High Affinities for Heparin and Endothelial Cell Proteoglycans* , 2000, The Journal of Biological Chemistry.

[60]  H. Gabius,et al.  Detection of ligand- and solvent-induced shape alterations of cell-growth-regulatory human lectin galectin-1 in solution by small angle neutron and x-ray scattering. , 2003, Biophysical journal.

[61]  R. Read,et al.  Structure of a pertussis toxin–sugar complex as a model for receptor binding , 1994, Nature Structural Biology.

[62]  R. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.

[63]  H. Gabius,et al.  Lectin-Mediated Drug Targeting: Selection of Valency, Sugar Type (Gal/Lac), and Spacer Length for Cluster Glycosides as Parameters to Distinguish Ligand Binding to C-Type Asialoglycoprotein Receptors and Galectins , 2000, Pharmaceutical Research.

[64]  L. Wyns,et al.  An Unusual Carbohydrate Binding Site Revealed by the Structures of Two Maackia amurensis Lectins Complexed with Sialic Acid-containing Oligosaccharides* , 2000, The Journal of Biological Chemistry.

[65]  Lurong Zhang,et al.  Hyaluronan‐binding peptide can inhibit tumor growth by interacting with Bcl‐2 , 2004, International journal of cancer.

[66]  H Kaltner,et al.  Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3* , 2001, The Journal of Biological Chemistry.

[67]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[68]  N V Bovin,et al.  Endogenous lectins as targets for drug delivery. , 2000, Advanced drug delivery reviews.

[69]  K. Kayser,et al.  Galectins-1 and -3 and their ligands in tumor biology , 1999, Journal of Cancer Research and Clinical Oncology.

[70]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.